Clinical observation and evaluation of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western Medicine
- Conditions
- COVID-19
- Registration Number
- ITMCTR2000003113
- Lead Sponsor
- Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) mild / general patients who meet the diagnostic criteria of the Protocol;
(2) Aged >=18 years;
(3) Obtain patients' informed consent.
(1) Patients who cannot guarantee medication compliance during treatment, and patients who have difficulty in oral administration;
(2) Patients more than 7 days after diagnosis;
(3) Patients with severe primary respiratory diseases, or patients with other pathogenic microbial pneumonia that needs to be identified with NCP;
(4) pregnant women, those with positive urine pregnancy tests;
(5) Combined with other systemic malignant diseases such as malignant tumors and mental diseases;
(6) Patients with other serious diseases such as uremia and severe heart failure;
(7) Those who are allergic to the test drugs or who are intolerant to taking the drugs;
(8) Patients that the investigator considers unsuitable to participate in the study.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ALT, AST, gama-GT, BUN, Cr, CK-MB;Average discharge time;turn serious/crisis ratio;WBC;
- Secondary Outcome Measures
Name Time Method